FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W196767433> ?p ?o ?g. }

• W196767433 endingPage "41" @default.
• W196767433 startingPage "1233" @default.
• W196767433 abstract "This study was designed to determine the effect of cyclocreatine on the release of neutrophil chemotactic factors (NCF) from isolated rabbit hearts. We tested the hypothesis that if ischemia is important for the formation of NCF from the myocardium, then blocking (or delaying) ischemic changes with cyclocreatine should inhibit the release of NCF. Two models were used, including (1) perfusion of rabbit hearts (Langendorff apparatus) with oxygenated (95% oxygen) Krebs-Henseleit buffer (K-H buffer) containing 5% cyclocreatine for 120 minutes, and (2) incubating hearts with phosphate-buffered saline (PBS) containing 5% cyclocreatine for 120 minutes. For both models, rabbits were injected intravenously with 10 ml of 5% cyclocreatine solution 30 minutes before the animals were killed and the hearts removed. Control rabbits were injected with 5% creatine solution or saline for 30 minutes before perfusing hearts with K-H buffer or incubating with PBS. Chemotactic activity was assayed in the perfusates and supernatants using modified Boyden chambers and rabbit peritoneal neutrophils as indicator cells. The chemoattractant f-Met-Leu-Phe (f-MLP) was the positive control for a 100% response rate. Isolated hearts perfused with cyclocreatine showed significantly lower chemotactic activity (ie, 1.24 +/- 1% f-MLP; P less than 0.0001) compared to hearts perfused with K-H buffer (129 +/- 18%) or creatine (227 +/- 42%) (mean +/- standard error). Similar results were obtained using incubated hearts. Next the effect of cyclocreatine on neutrophils in the Boyden chamber was determined and it was found that it did not alter neutrophil migration, which excludes a direct inhibitory effect on the cells. Furthermore supernatant from cyclocreatine-treated hearts did not inhibit neutrophil chemotaxis to C5a, indicating absence of a chemotaxis inhibitor in this preparation. Results of these studies suggest that the observed low activity recovered in perfusate and supernatant of cyclocreatine-treated hearts is a result of reduction in the synthesis and/or release of the factors from myocardial tissues. Similar to previously established data, cyclocreatine treatment significantly preserved myocardial nucleotide levels (ie, adenosine triphosphate and creatine phosphate), which supports our hypothesis that the formation of NCF is ischemia dependent and that maintaining elevated levels of myocardial energy nucleotides reduced chemotactic factor release." @default.
• W196767433 created "2016-06-24" @default.
• W196767433 creator A5017843874 @default.
• W196767433 creator A5023787207 @default.
• W196767433 creator A5027336692 @default.
• W196767433 creator A5029157410 @default.
• W196767433 creator A5059243738 @default.
• W196767433 creator A5083643096 @default.
• W196767433 creator A5087281925 @default.
• W196767433 date "1990-11-01" @default.
• W196767433 modified "2023-09-25" @default.
• W196767433 title "Cyclocreatine inhibits the production of neutrophil chemotactic factors from isolated hearts." @default.
• W196767433 cites W103530802 @default.
• W196767433 cites W1483825026 @default.
• W196767433 cites W1486968954 @default.
• W196767433 cites W1496717455 @default.
• W196767433 cites W153136710 @default.
• W196767433 cites W1592252967 @default.
• W196767433 cites W1753169826 @default.
• W196767433 cites W1890393137 @default.
• W196767433 cites W1921239402 @default.
• W196767433 cites W1950345668 @default.
• W196767433 cites W1970196032 @default.
• W196767433 cites W1973311463 @default.
• W196767433 cites W1974045706 @default.
• W196767433 cites W1977984171 @default.
• W196767433 cites W1996078074 @default.
• W196767433 cites W2007379138 @default.
• W196767433 cites W2008755235 @default.
• W196767433 cites W2011513090 @default.
• W196767433 cites W2018783636 @default.
• W196767433 cites W2028939105 @default.
• W196767433 cites W2036917022 @default.
• W196767433 cites W2048050761 @default.
• W196767433 cites W2066349673 @default.
• W196767433 cites W2068283023 @default.
• W196767433 cites W2071701979 @default.
• W196767433 cites W2078958804 @default.
• W196767433 cites W2131100536 @default.
• W196767433 cites W2165968123 @default.
• W196767433 cites W2172336930 @default.
• W196767433 cites W2208015758 @default.
• W196767433 cites W2223311356 @default.
• W196767433 cites W2256874159 @default.
• W196767433 cites W2328570570 @default.
• W196767433 cites W2401074541 @default.
• W196767433 cites W2417185706 @default.
• W196767433 cites W2417873014 @default.
• W196767433 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1877674" @default.
• W196767433 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2240167" @default.
• W196767433 hasPublicationYear "1990" @default.
• W196767433 type Work @default.
• W196767433 sameAs 196767433 @default.
• W196767433 citedByCount "5" @default.
• W196767433 countsByYear W1967674332015 @default.
• W196767433 countsByYear W1967674332022 @default.
• W196767433 crossrefType "journal-article" @default.
• W196767433 hasAuthorship W196767433A5017843874 @default.
• W196767433 hasAuthorship W196767433A5023787207 @default.
• W196767433 hasAuthorship W196767433A5027336692 @default.
• W196767433 hasAuthorship W196767433A5029157410 @default.
• W196767433 hasAuthorship W196767433A5059243738 @default.
• W196767433 hasAuthorship W196767433A5083643096 @default.
• W196767433 hasAuthorship W196767433A5087281925 @default.
• W196767433 hasConcept C126322002 @default.
• W196767433 hasConcept C134018914 @default.
• W196767433 hasConcept C146957229 @default.
• W196767433 hasConcept C16685009 @default.
• W196767433 hasConcept C170493617 @default.
• W196767433 hasConcept C185592680 @default.
• W196767433 hasConcept C198677920 @default.
• W196767433 hasConcept C202751555 @default.
• W196767433 hasConcept C2777397205 @default.
• W196767433 hasConcept C2779866169 @default.
• W196767433 hasConcept C2779896295 @default.
• W196767433 hasConcept C43617362 @default.
• W196767433 hasConcept C54166955 @default.
• W196767433 hasConcept C55493867 @default.
• W196767433 hasConcept C71924100 @default.
• W196767433 hasConcept C86803240 @default.
• W196767433 hasConcept C96616956 @default.
• W196767433 hasConceptScore W196767433C126322002 @default.
• W196767433 hasConceptScore W196767433C134018914 @default.
• W196767433 hasConceptScore W196767433C146957229 @default.
• W196767433 hasConceptScore W196767433C16685009 @default.
• W196767433 hasConceptScore W196767433C170493617 @default.
• W196767433 hasConceptScore W196767433C185592680 @default.
• W196767433 hasConceptScore W196767433C198677920 @default.
• W196767433 hasConceptScore W196767433C202751555 @default.
• W196767433 hasConceptScore W196767433C2777397205 @default.
• W196767433 hasConceptScore W196767433C2779866169 @default.
• W196767433 hasConceptScore W196767433C2779896295 @default.
• W196767433 hasConceptScore W196767433C43617362 @default.
• W196767433 hasConceptScore W196767433C54166955 @default.
• W196767433 hasConceptScore W196767433C55493867 @default.
• W196767433 hasConceptScore W196767433C71924100 @default.
• W196767433 hasConceptScore W196767433C86803240 @default.
• W196767433 hasConceptScore W196767433C96616956 @default.

• next